{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:34:12Z","timestamp":1771605252295,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.029","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T07:30:19Z","timestamp":1405668619000},"page":"4938-4944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-2736","authenticated-orcid":false,"given":"Pauline","family":"Verdijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nynke Y.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique G.C.T.","family":"van Oijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Okayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried A.M.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.029_bib0005","unstructured":"Global eradication of poliomyelitis by the year 2000. Forty-first world health assembly. WHA41.281988."},{"key":"10.1016\/j.vaccine.2014.07.029_bib0010","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, November 2012 \u2013 conclusions and recommendations","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0015","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0020","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/593310","article-title":"New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis","volume":"47","author":"Chumakov","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0025","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1016\/j.vaccine.2010.08.023","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper\u2014recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0030","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/j.vaccine.2010.02.095","article-title":"The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox","volume":"28","author":"Heinsbroek","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biologicals.2006.02.011","article-title":"Technology transfer of Sabin-IPV to new developing country markets","volume":"34","author":"Kreeftenberg","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/erv.11.51","article-title":"Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains","volume":"10","author":"Verdijk","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0045","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit155","article-title":"Phase II and III clinical studies of diphtheria-tetanus-acellular pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV)","volume":"208","author":"Okada","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0055","unstructured":"Adsorbed Purified Pertussis Diptheria Tetanus Inactivated Poliomyelitis (Sabin strain) Combined Vaccine. Notice of Marketing Authorization Approval, July 27, 2012. Astellas Pharma Inc. Available at: http:\/\/www.astellas.com\/en\/corporate\/news\/pdf\/120727_Eg.pdf [accessed 11.02.14]."},{"key":"10.1016\/j.vaccine.2014.07.029_bib0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1539-6924.2006.00840.x","article-title":"Risk management in a polio-free world","volume":"26","author":"Aylward","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/434699a","article-title":"A global call for new polio vaccines","volume":"434","author":"Heymann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0075","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0080","first-page":"119","article-title":"Potency testing of killed polio vaccine in rats","volume":"47","author":"van Steenis","year":"1981","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/biol.1995.0049","article-title":"A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines","volume":"23","author":"Wood","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0090","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"Westdijk","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0100","doi-asserted-by":"crossref","first-page":"e83374","DOI":"10.1371\/journal.pone.0083374","article-title":"Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals","volume":"8","author":"Thomassen","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0105","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/j.vaccine.2013.09.021","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults","volume":"31","author":"Verdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0115","unstructured":"Report on the Deliberation Results, 23 July 2012. Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare. Available at: http:\/\/www.pmda.go.jp\/english\/service\/pdf\/drugs\/quattrovac_july2012_e.pdf [accessed 27.03.14]."},{"key":"10.1016\/j.vaccine.2014.07.029_bib0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0125","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/424524","article-title":"Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy","volume":"190","author":"Dragunsky","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0130","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1016\/j.vaccine.2007.07.060","article-title":"Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains","volume":"25","author":"Tano","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.029_bib0135","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"17","author":"Kersten","year":"1999","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T09:55:57Z","timestamp":1538387757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14009554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":27,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14009554"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}